Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, and Neuroinflammation and Neurodegeneration Mechanisms.
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology
Proteomic analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with <i>APOE</i> ε4 and atomoxetine treatment
Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid
Differential DNA methylation in the brain as potential mediator of the association between traffic‐related PM<sub>2.5</sub> and neuropathology markers of Alzheimer's disease
Association between Fine Particulate Matter Exposure and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease among a Cognitively Healthy Population-Based Cohort
Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer’s disease
Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment
Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals
Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome
CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
Automated analysis of facial emotions in subjects with cognitive impairment
The complex relationship of air pollution and neighborhood socioeconomic status and their association with cognitive decline
Neighborhood characteristics as confounders and effect modifiers for the association between air pollution exposure and subjective cognitive functioning
Brain microRNAs are associated with variation in cognitive trajectory in advanced age
Alzheimer's disease genetic burden is associated with mid‐life depression among persons with normal cognition
Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Brain proteome-wide association study implicates novel proteins in depression pathogenesis
A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer's disease
Extracellular signal‐regulated kinase regulates microglial immune responses in Alzheimer’s disease
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
Genetic Evidence Supporting a Causal Role of Depression in Alzheimer’s Disease
Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue